Dr. Lynch Discusses Challenges Associated With Molecular Targeted Therapies in Lung Cancer
Thomas J. Lynch, MD, director, Yale Cancer Center, physician-in-chief, Smilow Cancer Hospital at Yale-New Haven, discusses challenges associated with treating patients with lung cancer with molecular targeted therapies. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Suggested videos

Dr. Tom Lynch on Leadership, Innovation and Cancer Research
Fred Hutch · 24:31

INICET AIR-93... What!! Radiation Oncology??
Dr. Dhruva Gupta · 9:15

2026 IASLC Targeted Therapies of Lung Cancer: Special Presentation by Dr. Ross Camidge
IASLC · 24:29

Managing ALK-Positive Lung Cancer: Treatment Strategies and Sequencing
LifeCell Diagnostics · 1:00:39

Advances in Lung Cancer Care: Targeted Therapies, Robotic Surgery & Beyond
Baptist Health · 41:13

Advancements in Care Through Precision Oncology
Canadian Breast Cancer Network · 1:28:26

Dr. Herbst Discusses New Immunotherapy Agents for Lung Cancer
OncLive · 1:20

Precision Oncology: Changing the Game for Metastatic Cancer
Health Uncensored With Dr. Drew · 4:50

10/16/2015: "Evolution of Targeted Therapies in Breast Cancer: New Opportunities for Cure"
UW Department of Medicine · 56:54

Emerging Treatments in Pancreatic Cancer
National Pancreas Foundation · 59:48

Dr. Reckamp on Targeted Therapy Options for Rare Mutations in NSCLC
OncLive · 1:11

David R Spigel MD; ASCO 2026: EGFR Exon-20 Insertion Directed Initial Therapy Cuts Disease…
Audio Journal of Oncology · 3:55